Acquisition by David Portnoy of 25000 shares of CryoCell International at 12.27 subject to Rule 16b-3

CCEL Stock  USD 8.67  0.42  4.62%   
About 61% of CryoCell International's investor base is looking to short. The analysis of overall sentiment of trading CryoCell International stock suggests that many investors are alarmed at this time. CryoCell International's investing sentiment shows overall attitude of investors towards CryoCell International.
  
Filed transaction by CryoCell International Director, Officer Chairman, Co-ceo. Grant, award or other acquisition pursuant to Rule 16b-3

Read at macroaxis.com
Acquisition of 25000 stock option at 12.27 of CryoCell International by David Portnoy on 2nd of July 2024. This event was filed by CryoCell International with SEC on 2021-12-22. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

CryoCell International's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the CryoCell International's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

CryoCell International Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards CryoCell International can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

CryoCell International Fundamental Analysis

We analyze CryoCell International's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CryoCell International using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CryoCell International based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Target Price

Target Price Comparative Analysis

CryoCell International is currently under evaluation in target price category among its peers.

CryoCell International Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with CryoCell International stock to make a market-neutral strategy. Peer analysis of CryoCell International could also be used in its relative valuation, which is a method of valuing CryoCell International by comparing valuation metrics with similar companies.

Peers

CryoCell International Related Equities

PIIIP3 Health   4.17   
0%
70.0%
AVAHAveanna Healthcare   4.12   
0%
70.0%
SEMSelect Medical   3.73   
0%
63.0%
CCMConcord Medical   3.25   
0%
55.0%
AIRSAirsculpt Technologies   2.86   
0%
48.0%
DCGODocGo   1.86   
0%
31.0%
SGRYSurgery Partners   1.84   
0%
31.0%
BKDBrookdale Senior   1.61   
0%
27.0%
INNVInnovAge Holding   1.46   
0%
24.0%
MDMednax   1.29   
0%
21.0%
SNDASonida Senior   0.89   
0%
15.0%
NHCNational HealthCare   0.59   
0%
10.0%
ENSGEnsign   0.16   
0%
2.0%
EHCEncompass Health   0.1   
0%
1.0%
PNTGPennant   0.67   
11.0%
0%
ACHCAcadia Healthcare   1.57   
26.0%
0%
TOIOncology Institute   5.88   
100.0%
0%
When determining whether CryoCell International is a strong investment it is important to analyze CryoCell International's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CryoCell International's future performance. For an informed investment choice regarding CryoCell Stock, refer to the following important reports:
Check out CryoCell International Hype Analysis, CryoCell International Correlation and CryoCell International Performance.
For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CryoCell International. If investors know CryoCell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CryoCell International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.625
Earnings Share
(1.07)
Revenue Per Share
3.89
Quarterly Revenue Growth
0.025
Return On Assets
(0)
The market value of CryoCell International is measured differently than its book value, which is the value of CryoCell that is recorded on the company's balance sheet. Investors also form their own opinion of CryoCell International's value that differs from its market value or its book value, called intrinsic value, which is CryoCell International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CryoCell International's market value can be influenced by many factors that don't directly affect CryoCell International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CryoCell International's value and its price as these two are different measures arrived at by different means. Investors typically determine if CryoCell International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CryoCell International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.